S, H., M, B., & M, H. (2022). Screening and management of subclinical interstitial lung disease in systemic sclerosis: An international survey. Rheumatology (Oxford, England), 61(8), 3401. https://doi.org/10.1093/rheumatology/keab929
Chicago Style (17th ed.) CitationS, Hoa, Baron M, and Hudson M. "Screening and Management of Subclinical Interstitial Lung Disease in Systemic Sclerosis: An International Survey." Rheumatology (Oxford, England) 61, no. 8 (2022): 3401. https://doi.org/10.1093/rheumatology/keab929.
MLA (9th ed.) CitationS, Hoa, et al. "Screening and Management of Subclinical Interstitial Lung Disease in Systemic Sclerosis: An International Survey." Rheumatology (Oxford, England), vol. 61, no. 8, 2022, p. 3401, https://doi.org/10.1093/rheumatology/keab929.